U
CVR Medical Corp. CVMH.V
TSX
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022 03/31/2022 12/31/2021 09/30/2021
Net Income -6.20% -229.05% 59.85% -268.88% 21.88%
Total Depreciation and Amortization -100.00% -100.00% -100.00% 0.00% 0.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -41.40% 103.31% -83.37% 321.67% -73.56%
Change in Net Operating Assets -54.54% -11.20% -67.80% 200.89% 480.95%
Cash from Operations -201.60% -429.93% -470.65% -114.61% 68.12%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -55.56% -100.00% -68.15% 3.02% -26.43%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -55.56% 57.34% -68.15% 342.64% -26.43%
Foreign Exchange rate Adjustments 302.74% 206.21% -93.45% 106.04% -68.12%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -834.29% 1,390.00% -6,909.09% 3,684.00% 107.61%
Weiss Ratings